were sensitized with antibodies against normal mouse erythrocytes.
The mechanisms of protective immunity against the erythrocytic stages of malaria parasites are not completely known. Antibody, cell-mediated, and lymphokine responses are elicited during the erythrocytic cycle (for a review, see reference 23). However, in different experimental systems, different effector mechanisms of immunity appear to be operative. Immunity to Plasmodium yoelii appears to have a strong humoral component (9) , whereas immunity to P. chabaudi can be achieved in mice that are B cell deficient (8) . Thus, the effector mechanism that would be most important in immunization protocols against malaria is still not known.
Both in human (3, 13, 15, 21) and rodent (16, 29) malarias, several plasmodial antigens are expressed in the membranes of infected erythrocytes, some of which are exposed on the surface of the erythrocytic membrane (13, 15) . Therefore, cytotoxicity directed against the erythrocyte membrane would appear to be a potential protective mechanism. Antibody-dependent cell-mediated cytotoxicity (ADCC) is an effector mechanism which operates against tumor cells and other target cells sensitized with specific antibodies against surface membrane antigens and which is mediated by a subpopulation of heterogeneous lymphocytes called K cells, as well as by mononuclear cells and granulocytes (for a review, see reference 22) .
ADCC has been observed when human mononuclear cells and malaria-immune serum are incubated with P. falciparum in culture (2) . However, a ratio of 50 mononuclear cells to 1 parasitized erythrocyte was necessary to demonstrate cytotoxicity when cells were taken from acutely infected children or noninfected adults. Other studies measured ADCC against unrelated targets during malarial infection. Gilbreath et al. (6) found ADCC depressed during human malarial infections when Chang cells were used as targets and unchanged when antibody-coated erythrocytic targets were used. In addition, ADCC against antibody-coated chicken erythrocytes was enhanced in mice infected with P. chabaudi (14) . Thus, the degree of ADCC during malarial infection may vary in different clinical and experimental situations and with infected erythrocytes or unrelated targets (1, 2, 6, 7, 14) .
To clarify some of these observations, I used experimental models of rodent malaria. I against 51Cr-labeled mouse erythrocytes (moEIgG) (11) . Although this study did not attempt to define the effector cell population mediating ADCC, activated macrophages appeared to be the predominant effector cells. Esterase staining (10) of the spleen cell populations indicated that 13% + 8% of the cells were esterase positive on day 5 of P. berghei infection, 60% + 8% were positive on day 11, and 61% + 7% were positive on day 14, compared with 8% + 5% in normal mouse spleen cell suspensions. Furthermore, mature B and T cells do not appear to mediate ADCC (22) . Effector and target cells at various concentrations and ratios were suspended in Dulbecco modified Eagle medium containing 10% heat-inactivated fetal calf serum (lot 1101518; Flow Laboratories, Inc., McLean, Va.), 100 U of penicillin per ml, 100 mg of streptomycin per ml, and 20 mM glutamine (GIBCO Laboratories, Grand Island, N.Y.). Assays were conducted in triplicate in flat-bottom microdilution plates (Becton Dickinson Labware, Oxnard, Calif.) (31) . Each well contained 50 ,ul of normal mouse erythrocytes (109 cells per ml) as a cushion, 100 ,ul of effector cells, and 100 ,ul of target cells. (Similar results were obtained without the normal erythrocyte cushion.) The plates were centrifuged at 50 x g and then placed in a 37°C incubator with 7.5% CO2 and 100% humidity for 4 or 18 h. After incubation, the plates were spun at 500 x g, and 100 ,u1 of the supernatant was removed for counting in a gamma counter. The maximum amount of releasable 51Cr was determined by incubating a sample of each target cell suspension in each experiment with 0.001% Triton X-100. The percentage of 51Cr released was calculated as previously described (11 cells from the spleens of several mice. This was probably because the incubation times were relatively short.
There was a striking enhancement of ADCC against moEIgG 4 days after infection with P. berghei, compared with that of normal cells (P < 0.001; parasitemia, <1%) (Fig.  1 ). Activity at this time was approximately four times that obtained with normal cells at a ratio of 10 effector cells to 1 target cell. On day 7, when parasitemia was 5%, cytotoxicity was also increased compared with that of normal spleen cells but was not as great as on day 4 (P < 0.001 at a ratio of 10: 1, P < 0.01 at 5:1, and P < 0.05 at 2.5:1). The increased activity may have been due to an increase in the proportion of effector cells in the spleen or an increase in the cytotoxic activity in the effector cell population. However, on days 14 and 21 (at parasitemias of 12 and 42%, respectively), ADCC activity was not detectable above background (counts per minute of 51Cr released in the absence of effector cells).
ADCC of spleen cells from normal mice and mice infected with either the nonlethal (17xNL) or lethal (17xL) variant of P. yoelii (a gift of William Weidanz) is shown in Fig. 2 . Significantly more lysis was obtained on day 6 with spleen cells from mice infected with the nonlethal variant (parasitemia, 1.5%) than with spleen cells obtained from normal mice (P < 0.01). In addition, I observed a decline in cytotoxicity later in the course of P. yoelii 17xNL infection (parasitemia on day 12, 12.5%) similar to that observed during P. berghei infection (Fig. 1) . In contrast, cytotoxicity of spleen cells from mice infected with P. yoelii 17xL (parasitemia, 8.5% on day 6 and 56% on day 12) was inhibited compared with that of cells from normal mice (P < 0.01).
In both P. berghei and P. yoelii 17xNL infections, levels of cytotoxicity, although higher than in normal mice, declined with increasing parasitemia. However, the differences in cytotoxicity cannot be attributed only to the degree of parasitemia, since greater cytotoxicity was observed with spleen cells obtained on day 12 from mice infected with P. To determine whether immune complexes present in the sera of P. berghei-infected mice (26) modulate ADCC, serum samples were obtained on days 7, 14, and 21 after infection of mice with P. berghei. The samples, at dilutions of 1:2, 1: 4, and 1:8, were added to activated macrophages (peritoneal cells obtained from mice which had been treated intraperitoneally with 400 ,ug of chloroquine per mouse for 3 days and challenged with 5 x 104 P. berghei-infected erythrocytes), and cytotoxicity against moEIgG was assayed. Challenged macrophages were used to obtain maximum cytotoxicity. The results of a typical experiment are shown in Fig. 3 . Serum samples obtained 2 weeks after infection completely inhibited ADCC at a dilution of 1:2 and inhibited cytotoxicity approximately 20% at a dilution of 1:4, compared with samples obtained from normal mice or from mice after 1 week of infection. Serum samples obtained on day 21 of infection were completely inhibitory at dilutions of both 1:2 and 1:4 and were about 40% inhibitory at a dilution of 1:8.
Serum samples obtained 3 weeks after infection were fractionated on Sephacryl S-300 to partially purify immune complexes (26) . The high-molecular-weight peak obtained for the sera of heavily infected mice indicated 30% cytotoxicity inhibition, whereas material obtained from normal mice had a minimal effect (6% inhibition). These results were statistically significant (P < 0.02).
In a previous study (20) , we found that clearance of IgG-sensitized erythrocytes was enhanced during the early phase of infection and declined later in the course of the disease. Immune complexes were thought to play a role in the inhibition of clearance, since sera from infected animals and immune complexes partially purified from these sera inhibited phagocytosis of IgG-sensitized erythrocytes in vitro (26, 27) . Since both phagocytosis of IgG-coated particles and ADCC are mediated by Fc receptors, it is not surprising that both activities show the same defect. ADCC appears to be a nonphagocytic reaction, since EDTA inhibits phagocytosis but not cytotoxicity (25) . The cytotoxic lesion in the erythrocyte causes increased osmotic fragility which precedes lysis (24) . In our studies, EDTA did not ablate lysis of either moEIgG or plasmodium-parasitized erythrocytes sensitized with IgG (data not shown).
It is not clear whether the depression in ADCC during the later stages of infection was due only to the presence of immune complexes or whether other suppressive mechanisms were operative. Cytotoxicity of spleen cells obtained from mice infected with the lethal strain of P. yoelii was actually lower at a higher effector-to-target ratio (Fig. 2) , suggesting that a suppressor cell may have been present in this population. Others have found evidence for suppressive adherent cells in the spleens of mice infected with P. yoelii (30) and P. chabaudi (4) and for suppressive cells in peripheral blood lymphocytes of humans infected with P. falciparum (28) .
Since ADCC is clearly enhanced at some points during malarial infection and with some strains, it was important to determine whether parasitized erythrocytes would be lysed in this assay. Furthermore, both human (5) and rodent (12) infected erythrocytes have been shown to be coated with IgG, which might mediate ADCC. In several experiments, P. berghei-infected erythrocytes could not be lysed by activated peritoneal macrophages, even after the infected cells were presensitized with hyperimmune serum. However, when P. berghei-infected erythrocytes were presensitized with rabbit anti-mouse erythrocyte IgG, they did release 51Cr, although less than that released by moEIgG (Table 1) . This result could reflect lysis of only uninfected erythro- c Rabbit anti-mouse erythrocyte antibody was raised and purified on Sephadex G-200 as described elsewhere (20) .
d Hyperimmune sera (diluted 1:10) against P. berghei-infected erythrocytes were obtained from mice which had been infected, treated with chloroquine, and challenged three times with 5 x 104 P. berghei-infected erythrocytes.
cytes; however, since the amount of 51Cr released was reduced by less than 50% compared with that from normal mouse erythrocytes, this explanation is unlikely. Another possible explanation is that malarial antigens on the erythrocyte surface are continuously shed. In this regard, it is interesting that several erythrocyte membrane malarial antigens must be fixed with glutaraldehyde to be detected (16, 21, 29) . It is also possible that although 51Cr was not released from parasitized erythrocytes in the presence of hyperimmune serum, the parasites were damaged or destroyed. In other studies, we found that H202 released from macrophages can reduce the ability of intraerythrocytic parasites to incorporate tritiated amino acids (19) and to multiply in vitro (18) . Furthermore, the in vitro assay of cytotoxicity cannot approximate the interaction between effector and target cells in an architecturally intact spleen.
Finally, another level of control in the expression of ADCC observed in the P. yoelii system was whether the infection was lethal or nonlethal. Preliminary data suggest that peritoneal and spleen cells from mice infected with the nonlethal variant secrete more H202 than do those from mice infected with the lethal variant, upon being triggered with the secretagogue phorbol myristate acetate. Since ADCC is mediated by H202 (17) , this may explain the increase in activity in the nonlethal infection.
The results reported here indicate that ADCC varies markedly during the course of malaria. Enhanced ADCC may also reflect the activation of other immune effector mechanisms during malarial infection. Our system also appears to be valuable in dissecting the differences between lethal and nonlethal malarial infections and possible suppressor mechanisms in such infections. 
